Markedly enhanced colon tumorigenesis in ApcMin mice lacking glutathione S-transferase Pi

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 49, 2009, Pages 20859-20864

  Ritchie, Kenneth J ^a   Walsh, Shaun ^b   Sansom, Owen J ^c   Henderson, Colin J ^a   Wolf, C Roland ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

Cancer; Colorectal; Inflammation

Indexed keywords

3 NITROTYROSINE; GAMMA INTERFERON; GLUTATHIONE TRANSFERASE P1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 4; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CANCER SURVIVAL; CARCINOGENESIS; COLITIS; COLON ADENOMA; COLON CANCER; COLON TUMOR; COLORECTAL ADENOMA; CONTROLLED STUDY; DESCENDING COLON; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LARGE INTESTINE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOMA; ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; CELL MOVEMENT; COLON; COLONIC NEOPLASMS; ENTEROCYTES; GLUTATHIONE S-TRANSFERASE PI; INFLAMMATION; MICE; OXIDATIVE STRESS; PRECANCEROUS CONDITIONS; SURVIVAL ANALYSIS;

MUS;

EID: 73949135434     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0911351106     Document Type: Article

References (41)

1. Eaton DL, Bammler TK (1999) Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci 49:156-164.
2. Henderson CJ, et al. (1998) Increased skin tumorigenesis in mice lacking Pi class glutathione S-transferases. Proc Natl Acad Sci USA 95:5275-5280.
3. Ritchie KJ, et al. (2007) Glutathione transferase Pi plays a critical role in the development of lung carcinogenesis following exposure to tobacco-related carcinogens and urethane. Cancer Res 67:9248-9257.
4. Henderson CJ, et al. (2000) Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi. Proc Natl Acad Sci USA 97:12741-12745.
5. Adler V, et al. (1999) Regulation of JNK signaling by GSTp. EMBO J 18:1321-1334.
6. Wu Y, et al. (2006) Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene 25:5787-5800.
7. Townsend DM, et al. (2009) Novel role for glutathione S-transferase Pi. Regulator of protein S-Glutathionylation following oxidative and nitrosative stress. J Biol Chem 284:436-445.
8. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759-767.
9. Smith G, et al. (2002) Mutations in APC, Kirsten-ras, and p53-alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci USA 99:9433-9438.
10. Su LK, et al. (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256:668-670.
11. Rubinfeld B, et al. (1996) Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 272:1023-1026.
12. Haigis KM, Caya JG, Reichelderfer M, Dove WF (2002) Intestinal adenomas can develop with a stable karyotype and stable microsatellites. Proc Natl Acad Sci USA 99:8927-8931.
13. Luongo C, Moser AR, Gledhill S, Dove WF (1994) Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res 54:5947-5952.
14. Gate L, Majumdar RS, Lunk A, Tew KD (2004) Increased myeloproliferation in glutathione S-transferase Pi-deficient mice is associated with a deregulation of JNK and Janus kinase/STAT pathways. J Biol Chem 279:8608-8616.
15. Ruscoe JE, et al. (2001) Pharmacologic or genetic manipulation of glutathione Stransferase P1-1 (GSTpi) influences cell proliferation pathways. J Pharmacol Exp Ther 298:339-345.
16. Linden SK, Sutton P, Karlsson NG, Korolik V, McGuckin MA (2008) Mucins in the mucosal barrier to infection. Mucosal Immunol 1:183-197.
17. Xia C, Hu J, Ketterer B, Taylor JB (1996) The organization of the human GSTP1-1 gene promoter and its response to retinoic acid and cellular redox status. Biochem J 313: 155-161.
18. Xia C, Taylor JB, Spencer SR, Ketterer B (1993) The human glutathione S-transferase P1-1 gene: modulation of expression by retinoic acid and insulin. Biochem J 292: 845-850.
19. Lo HW, et al. (2008) Identification and functional characterization of the human glutathione S-transferase P1 gene as a novel transcriptional target of the p53 tumor suppressor gene. Mol Cancer Res 6:843-850.
20. Wang JS, et al. (1999) Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China. J Natl Cancer Inst 91:347-354.
21. Rao CV, et al. (2005) Colonic tumorigenesis in BubR1+/-ApcMin/+ compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability. Proc Natl Acad Sci USA 102:4365-4370.
22. Batlle E, et al. (2005) EphB receptor activity suppresses colorectal cancer progression. Nature 435:1126-1130.
23. Cho NL, Javid SH, Carothers AM, Redston M, BertagnolliMM(2007) Estrogen receptors alpha and beta are inhibitory modifiers of Apc-dependent tumorigenesis in the proximal colon of Min/+ mice. Cancer Res 67:2366-2372.
24. Gounaris E, et al. (2007) Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci USA 104:19977-19982.
25. Andoh A, et al. (2006) Immunohistochemical study of chymase-positive mast cells in inflammatory bowel disease. Oncol Rep 16:103-107.
26. He SH (2004) Key role of mast cells and their major secretory products in inflammatory bowel disease. World J Gastroenterol 10:309-318.
27. Chung YC, Chang YF (2003) Serum interleukin-6 levels reflect the disease status of colorectal cancer. J Surg Oncol 83:222-226.
28. Schneider MR, et al. (2000) Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. Cancer Lett 151:31-38.
29. Becker C, et al. (2004) TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity 21:491-501.
30. McLoughlin RM, et al. (2003) Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation. J Clin Invest 112:598-607.
31. Hong F, et al. (2002) Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: Regulation by SOCS. J Clin Invest 110:1503-1513.
32. Luo L, et al. (2008) Recombinant protein glutathione S-transferases P1 attenuates inflammation in mice. Mol Immunol 46:848-857.
33. Zhou J, et al. (2008) Glutathione transferase P1: an endogenous inhibitor of allergic responses in a mouse model of asthma. Am J Respir Crit Care Med 178:1202-1210.
34. Dinkova-Kostova AT, Talalay P (2008) Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol Nutr Food Res 52 Suppl 1:S128-S138.
35. Hussain SP, et al. (2008) Nitric oxide is a key component in inflammation-accelerated tumorigenesis. Cancer Res 68:7130-7136.
36. Bevins CL (2006) Paneth cell defensins: key effector molecules of innate immunity. Biochem Soc Trans 34:263-266.
37. Ramasundara M, Leach ST, Lemberg DA, Day AS (2009) Defensins and inflammation: the role of defensins in inflammatory bowel disease. J Gastroenterol Hepatol 24:202-208.
38. Shaulian E, Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131-E136.
39. Hussain SP, Harris CC (2007) Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 121:2373-2380.
40. Dietrich WF, et al. (1993) Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75:631-639.
41. Sansom OJ et al. (2004) Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev 18:1385-1390.